Tempus AI, Inc. (NASDAQ:TEM) CAO Sells $125,545.06 in Stock

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 1,858 shares of Tempus AI stock in a transaction on Wednesday, February 5th. The shares were sold at an average price of $67.57, for a total value of $125,545.06. Following the transaction, the chief accounting officer now owns 55,379 shares in the company, valued at $3,741,959.03. This represents a 3.25 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Tempus AI Stock Performance

NASDAQ TEM traded up $3.97 during trading on Friday, hitting $68.96. 16,292,734 shares of the company traded hands, compared to its average volume of 11,766,354. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $79.49. The business has a fifty day simple moving average of $44.36 and a 200 day simple moving average of $48.84. The company has a debt-to-equity ratio of 8.17, a current ratio of 2.69 and a quick ratio of 2.55.

Wall Street Analyst Weigh In

Several equities analysts have weighed in on the company. Guggenheim started coverage on Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 target price on the stock. Bank of America boosted their price objective on shares of Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a research report on Friday, December 13th. Loop Capital cut their target price on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a research report on Tuesday, January 14th. Wolfe Research assumed coverage on shares of Tempus AI in a report on Friday, December 13th. They set an “outperform” rating and a $60.00 price target on the stock. Finally, TD Cowen reaffirmed a “buy” rating and issued a $74.00 price target (up from $58.00) on shares of Tempus AI in a research note on Wednesday. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, Tempus AI has an average rating of “Moderate Buy” and a consensus target price of $58.55.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in TEM. ARK Investment Management LLC grew its holdings in Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock valued at $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. NEA Management Company LLC grew its position in Tempus AI by 17.8% in the 3rd quarter. NEA Management Company LLC now owns 5,385,979 shares of the company’s stock worth $304,846,000 after purchasing an additional 813,169 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its position in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Tempus AI by 1.0% during the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock worth $45,920,000 after purchasing an additional 8,387 shares in the last quarter. Finally, Millennium Management LLC bought a new stake in shares of Tempus AI during the second quarter valued at approximately $8,067,000. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.